Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3-month randomized double-blind placebo-controlled trial of SRA-333 versus donepezil in mild to moderate Alzheimer's disease
2004-000016-10Phase 2Completed
- Sponsor
- Wyeth
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lecozotan in Alzheimer's disease (AD) (5 arms), sponsored by Wyeth. Primary endpoints: Change from baseline in ADAS-Cog total score at week 12 and ADCS-CGIC at week 12. Started Aug 2004; status: completed.
02
Drugs
lecozotan
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2004-000016-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000016-10.